{"id":"NCT02347085","sponsor":"Pearl Therapeutics, Inc.","briefTitle":"24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI","officialTitle":"A Randomized, Phase IIIb, Two-period, Two-treatment Double-blind, Multi-center, Crossover Study to Evaluate the 24-hour Lung Function Profile in Subjects With Moderate to Very Severe COPD After 4 Weeks of Treatment With PT003 and Placebo MDI","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-02-01","primaryCompletion":"2015-06-01","completion":"2015-06-01","firstPosted":"2015-01-27","resultsPosted":"2017-04-19","lastUpdate":"2018-07-19"},"enrollment":43,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["COPD"],"interventions":[{"type":"DRUG","name":"GFF MDI (PT003)","otherNames":["Glycopyrronium and Formoterol Fumarate Inhalation Aerosol; PT003, Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler (GFF MDI)"]},{"type":"DRUG","name":"Placebo MDI","otherNames":["Placebo Metered Dose Inhaler (MDI) for Glycopyrronium and Formoterol Fumarate Inhalation Aerosol"]}],"arms":[{"label":"GFF MDI (PT003)","type":"EXPERIMENTAL"},{"label":"Placebo MDI","type":"PLACEBO_COMPARATOR"}],"summary":"Randomized, Phase IIIb, Two-period, Two-treatment Double-blind, Multi-center, Crossover Study to Evaluate the 24-hour Lung Function Profile in Subjects with Moderate to Very Severe COPD after 4 Weeks of Treatment with PT003 and Placebo MDI","primaryOutcome":{"measure":"FEV1 AUC0-24 on Day 29","timeFrame":"Day 29","effectByArm":[{"arm":"GFF MD (PT003)","deltaMin":0.166,"sd":null},{"arm":"Placebo","deltaMin":-0.083,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28821260"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4137&filename=PT003012_Protocol_FINAL_31Dec14_Redacted.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":40},"commonTop":["Hypertenstion","Dyspnoea","Sinus Congestion"]}}